129 related articles for article (PubMed ID: 1569235)
1. Intraindividual variability in nifedipine pharmacokinetics and effects in healthy subjects.
Soons PA; Schoemaker HC; Cohen AF; Breimer DD
J Clin Pharmacol; 1992 Apr; 32(4):324-31. PubMed ID: 1569235
[TBL] [Abstract][Full Text] [Related]
2. Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipine.
Cheung WK; Sia LL; Woodward DL; Graveline JF; Desjardins RE; Yacobi A; Silber BM
J Clin Pharmacol; 1988 Nov; 28(11):1001-7. PubMed ID: 3243913
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G
Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients.
Roy LF; East DS; Browning FM; Shaw D; Ogilvie RI; Cardella C; Leenen FH
Clin Pharmacol Ther; 1989 Dec; 46(6):657-67. PubMed ID: 2689045
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers.
Soons PA; Cohen AF; Breimer DD
Eur J Clin Pharmacol; 1993; 44(2):113-20. PubMed ID: 8453956
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
Wu WH; Henderson BM; Lanc R; Garnes D; Yacobi A; Silber BM
Drug Metab Dispos; 1988; 16(2):222-7. PubMed ID: 2898337
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine infusion in acute myocardial infarction: experience in twelve patients.
Walley TJ; Heagerty AM; Woods KL; Bing RF; Pohl JE; Barnett DB
Clin Cardiol; 1987 Dec; 10(12):800-3. PubMed ID: 3690906
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral lidocaine and nifedipine in patients with liver cirrhosis.
Tonsuwannont W; Praisontarangkul OA; Manorot M; Klangwarnwong D
J Med Assoc Thai; 1996 May; 79(5):309-19. PubMed ID: 8708523
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine.
Bowles SK; Reeves RA; Cardozo L; Edwards DJ
J Clin Pharmacol; 1993 Aug; 33(8):727-31. PubMed ID: 8408733
[TBL] [Abstract][Full Text] [Related]
12. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
13. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
[TBL] [Abstract][Full Text] [Related]
14. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition.
Abernethy DR; Gutkowska J; Winterbottom LM
Clin Pharmacol Ther; 1990 Jul; 48(1):76-86. PubMed ID: 2142447
[TBL] [Abstract][Full Text] [Related]
15. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
van Harten J; Burggraaf J; van Brummelen P; Breimer DD
Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880
[TBL] [Abstract][Full Text] [Related]
16. [Effects of a calcium antagonist (nifedipine) in hypertensive and normotensive subjects].
MacCarthy GB; Sánchez Torres G; Barrera JG
Arch Inst Cardiol Mex; 1988; 58(2):137-43. PubMed ID: 2969712
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine: kinetics and dynamics in healthy subjects.
Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state.
Gutierrez LM; Lesko LJ; Whipps R; Carliner N; Fisher M
J Clin Pharmacol; 1986; 26(8):587-92. PubMed ID: 3793948
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.
Shaheen O; Zmeili S; al-Qussuois Y; Arafat T; Mouti H
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):337-41. PubMed ID: 1937993
[TBL] [Abstract][Full Text] [Related]
20. Effects of diltiazem on the pharmacokinetics of nifedipine.
Ohashi K; Tateishi T; Sudo T; Sakamoto K; Toyosaki N; Hosoda S; Toyo-oka T; Sugimoto K; Kumagai Y; Ebihara A
J Cardiovasc Pharmacol; 1990 Jan; 15(1):96-101. PubMed ID: 1688989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
